Literature DB >> 4110939

Vaccinia necrosum and its relationship to impaired immunologic responsiveness.

E R Freed, R J Duma, M R Escobar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4110939     DOI: 10.1016/0002-9343(72)90031-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  14 in total

1.  Vaccinia virus-specific CD8(+) T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humans.

Authors:  Masanori Terajima; Laura Orphin; Anita M Leporati; Pamela Pazoles; John Cruz; Alan L Rothman; Francis A Ennis
Journal:  Hum Immunol       Date:  2008-10-26       Impact factor: 2.850

2.  Langerhans cells at the sites of vaccinia virus inoculation.

Authors:  S Nagao; S Inaba; S Iijima
Journal:  Arch Dermatol Res       Date:  1976-07-26       Impact factor: 3.017

3.  Human antibody responses to the polyclonal Dryvax vaccine for smallpox prevention can be distinguished from responses to the monoclonal replacement vaccine ACAM2000.

Authors:  Christine Pugh; Sarah Keasey; Lawrence Korman; Phillip R Pittman; Robert G Ulrich
Journal:  Clin Vaccine Immunol       Date:  2014-04-23

4.  A viral, transporter associated with antigen processing (TAP)-independent, high affinity ligand with alternative interactions endogenously presented by the nonclassical human leukocyte antigen E class I molecule.

Authors:  Elena Lorente; Susana Infantes; David Abia; Eilon Barnea; Ilan Beer; Ruth García; Fátima Lasala; Mercedes Jiménez; Carmen Mir; Antonio Morreale; Arie Admon; Daniel López
Journal:  J Biol Chem       Date:  2012-08-27       Impact factor: 5.157

Review 5.  Smallpox and its post-eradication surveillance.

Authors:  Z Jezek; L N Khodakevich; J F Wickett
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

6.  Multiple viral ligands naturally presented by different class I molecules in transporter antigen processing-deficient vaccinia virus-infected cells.

Authors:  Elena Lorente; Susana Infantes; Eilon Barnea; Ilan Beer; Ruth García; Fátima Lasala; Mercedes Jiménez; Carlos Vilches; François A Lemonnier; Arie Admon; Daniel López
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

7.  Obligatory requirement for antibody in recovery from a primary poxvirus infection.

Authors:  Geeta Chaudhri; Vijay Panchanathan; Horst Bluethmann; Gunasegaran Karupiah
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

8.  Lung involvement in progressive vaccinia.

Authors:  D S Chudwin; M J Cowan; D W Wara; A C Johnson
Journal:  West J Med       Date:  1981-05

9.  Vaccinia virus-specific human CD4+ cytotoxic T-lymphocyte clones.

Authors:  R A Littaua; A Takeda; J Cruz; F A Ennis
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  Diverse recognition of conserved orthopoxvirus CD8+ T cell epitopes in vaccinated rhesus macaques.

Authors:  Stephen R Walsh; Jacqueline Gillis; Björn Peters; Bianca R Mothé; John Sidney; Alessandro Sette; R Paul Johnson
Journal:  Vaccine       Date:  2009-06-14       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.